ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementiasymptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis israel ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 6 mg - rivastigmine - rivastigmine - treatment of patients with mild to moderately severe dementia of the alzheimer type, also termed probable alzheimer's disease or alzheimer's disease.symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

novartis pharma services ag - rivastigmine 4.6 mg/day - patches - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.

ישראל - עברית - Ministry of Health

novartis pharma services ag - rivastigmine 9.5 mg/day - patches - rivastigmine - treatment of mild to moderate dementia of the alzheimer's type.

ישראל - עברית - Ministry of Health

inovamed ltd - rivastigmine as hydrogen tartrate 1.5 mg - capsules - rivastigmine - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia associated with parkinson's disease.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 1.5 mg - rivastigmine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 3 mg - rivastigmine

ישראל - עברית - Ministry of Health

rafa laboratories ltd - rivastigmine as hydrogen tartrate - קפסולות - rivastigmine as hydrogen tartrate 4.5 mg - rivastigmine